Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
2.910
-0.160 (-5.21%)
Jul 1, 2025, 10:57 AM - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $125.77 million as of July 1, 2025. Its market cap has decreased by -78.77% in one year.
Market Cap
125.77M
Enterprise Value
-103.03M
1-Year Change
-78.77%
Ranking
Category
Stock Price
$2.91
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $125.77M, a decrease of -86.00%. That is a compound annual growth rate of -75.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 132.68M | -17.82% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |